These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 5559387)

  • 1. Radiotoxicity of intranuclear tritium, 125 iodine and 131 iodine.
    Hofer KG; Hughes WL
    Radiat Res; 1971 Jul; 47(1):94-101. PubMed ID: 5559387
    [No Abstract]   [Full Text] [Related]  

  • 2. Kinetics of proliferation, migration, and death of L1210 ascites cells.
    Hofer KG; Hofer M
    Cancer Res; 1971 Apr; 31(4):402-8. PubMed ID: 5553686
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of tryptophan deprivation on L1210 cells in culture.
    Woolley PV; Dion RL; Bono VH
    Cancer Res; 1974 May; 34(5):1010-4. PubMed ID: 4856777
    [No Abstract]   [Full Text] [Related]  

  • 4. Death and metastatic distribution of tumor cells in mice monitored with 125I-iododeoxy-uridine.
    Hofer KG; Prensky W; Hughes WL
    J Natl Cancer Inst; 1969 Oct; 43(4):763-73. PubMed ID: 5344176
    [No Abstract]   [Full Text] [Related]  

  • 5. Rdiotoxicity of intracellular 67Ga, 125I and 3H. Nuclear versus cytoplasmic radiation effects in murine L1210 leukaemia.
    Hofer KG; Harris CR; Smith JM
    Int J Radiat Biol Relat Stud Phys Chem Med; 1975 Sep; 28(3):225-41. PubMed ID: 1081511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell population growth and cell loss in the MTG-B mouse mammary carcinoma.
    Clifton KH; Yatvin MB
    Cancer Res; 1970 Mar; 30(3):658-64. PubMed ID: 5425291
    [No Abstract]   [Full Text] [Related]  

  • 7. An evaluation of radioiodine-labeled 5-iodo-2'-deoxyuridine as a tracer for measuring cell loss from solid tumors.
    Dethlefsen LA
    Cell Tissue Kinet; 1971 Mar; 4(2):123-38. PubMed ID: 5128277
    [No Abstract]   [Full Text] [Related]  

  • 8. The influence of exogenous thymidine concentration on the incorporation of labelled thymidine and iododeoxyuridine, and on growth of JU56 cells in vitro.
    Moore RC; Martin RF; Hodgson GS
    Aust J Exp Biol Med Sci; 1973 Apr; 51(2):169-79. PubMed ID: 4736769
    [No Abstract]   [Full Text] [Related]  

  • 9. Autoradiographic and cytophotometric analyses of the resting stages of the L1210 ascites tumor.
    Hartmann NR; Dombernowsky P
    Cancer Res; 1974 Dec; 34(12):3296-302. PubMed ID: 4609606
    [No Abstract]   [Full Text] [Related]  

  • 10. [Studies on the incorporation of exogenic DNA in mammalian cells].
    Friedrich G; Feinendegen LE; Heiniger HJ
    Hoppe Seylers Z Physiol Chem; 1972 May; 353(5):705-6. PubMed ID: 5069277
    [No Abstract]   [Full Text] [Related]  

  • 11. Cytotoxicity and mode of action of 5-azacytidine on L1210 leukemia.
    Li LH; Olin EJ; Buskirk HH; Reineke LM
    Cancer Res; 1970 Nov; 30(11):2760-9. PubMed ID: 5487063
    [No Abstract]   [Full Text] [Related]  

  • 12. Cell loss from several types of solid murine tumour: comparison of 125I-iododeoxyuridine and tritiated thymidine methods.
    Begg AC
    Cell Tissue Kinet; 1977 Sep; 10(5):409-27. PubMed ID: 922795
    [No Abstract]   [Full Text] [Related]  

  • 13. Kinetics of effect of 1-beta-D-arabinofuranosylcytosine, its 5'-palmitoyl ester, 1-beta-D-arabinofuranosyluracil, and tritiated thymidine on the viability of cultured leukemia L1210 cells.
    Wilkoff LJ; Dulmadge EA; Lloyd HH
    J Natl Cancer Inst; 1972 Mar; 48(3):685-95. PubMed ID: 5058968
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of chemotherapy on the growth characteristics and cellular kinetics of leukemia L1210.
    Young RC; DeVita VT
    Cancer Res; 1970 Jun; 30(6):1789-94. PubMed ID: 5457940
    [No Abstract]   [Full Text] [Related]  

  • 15. Tumor immunity in vivo: use of the 125 IUdR prelabeling technique to monitor cell death in immune animals.
    Forman J; Ketchel MM; Hofer KG
    Transplantation; 1972 Aug; 14(2):166-74. PubMed ID: 5068223
    [No Abstract]   [Full Text] [Related]  

  • 16. Leukemia L1210 therapy trials with antileukemia serum and Bacillus Calmette-Guérin.
    Reif AE; Kim CA
    Cancer Res; 1971 Nov; 31(11):1606-12. PubMed ID: 5001090
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of selected piperazine derivatives on the metabolic clearance rate of idoxuridine-I-125 in mice with transplanted leukemia L1210].
    Graczyk J; Kowalczyk K; Pakulska W; Szadowska A
    Acta Pol Pharm; 1981; 38(6):717-21. PubMed ID: 7348532
    [No Abstract]   [Full Text] [Related]  

  • 18. Two components in L1210 cells and their growth characterization.
    Wakayama K; Besa EC; Baskin SI
    Nagoya J Med Sci; 1984 Mar; 46(1-4):125-42. PubMed ID: 6738677
    [No Abstract]   [Full Text] [Related]  

  • 19. Reutilization of thymidine and iododeoxyuridine by mouse mammary carcinoma strain MTG-B 1 .
    Clifton KH; Cooper JM
    Proc Soc Exp Biol Med; 1973 Apr; 142(4):1145-51. PubMed ID: 4694816
    [No Abstract]   [Full Text] [Related]  

  • 20. The thymidine-14C and -3H double-labeling technic in the study of the cell cycle of L1210 leukemia ascites tumor in vivo.
    Young RC; DeVita VT; Perry S
    Cancer Res; 1969 Aug; 29(8):1581-4. PubMed ID: 5807231
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.